This new issuance helps the Company continue to build our intellectual property estate for eltoprazine," said Gerald E. Commissiong, President & CEO of Amarantus
There is one caveat though if the product is out-licensed to them, they don't need to own the patent. That may be the case. However MANF is their intellectual property and they should be patent owners.